{"name":"Zimmer Biomet Holdings, Inc.","slug":"zimmer","ticker":"ZBH","exchange":"NYSE","domain":"zimmerbiomet.com","description":"Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.","hq":"Warsaw, IN","founded":0,"employees":"17000","ceo":"Ivan Tornos","sector":"MedTech / Orthopedics & Robotics","stockPrice":82.99,"stockChange":0.27,"stockChangePercent":0.33,"marketCap":"$16.1B","metrics":{"revenue":8409099776,"revenueGrowth":9.3,"grossMargin":70.2,"rdSpend":225600000,"netIncome":705100000,"cash":591900000,"dividendYield":1.16,"peRatio":21.5,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Persona Knee System patent cliff ($1.5B at risk)","drug":"Persona Knee System","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-08","type":"earnings","headline":"Zimmer Biomet Reports Fourth Quarter and Full Year 2023 Results","summary":"Zimmer Biomet Holdings, Inc. (ZBH) today announced its financial results for the fourth quarter and full year 2023. The company reported net sales of $1.8 billion for the fourth quarter and $7.3 billion for the full year 2023.","drugName":"","sentiment":"neutral"},{"date":"2023-09-21","type":"deal","headline":"Zimmer Biomet Announces Agreement to Acquire Orthofix's Spine and Biologics Business","summary":"Zimmer Biomet Holdings, Inc. (ZBH) today announced that it has entered into a definitive agreement to acquire the spine and biologics business of Orthofix International N.V. (OFIX).","drugName":"","sentiment":"positive"},{"date":"2023-06-15","type":"regulatory","headline":"Zimmer Biomet Receives FDA 510(k) Clearance for its Persona Revision Knee System","summary":"Zimmer Biomet Holdings, Inc. (ZBH) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Persona Revision Knee System.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE85TkwyaHlMek9HUzNtNXJCenVaN01Qc3Z6TGtXTlRTZlRPZVpvOTNfVFRvV3hNZ0ZaQ3h1Nm9zMnIyMEZpU0lpaGdnUzZVTEZXMTVYQmZuM1c3Zw?oc=5","date":"2026-04-02","type":"pipeline","source":"Bitget","summary":"NervGen Pharma Corp. Stock Chart | NASDAQ: NGEN Stock Price - Bitget","headline":"NervGen Pharma Corp. Stock Chart | NASDAQ: NGEN Stock Price","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE53Ulc0MVRkanRrTk40aHM3OVZvMGVnbjZsNlBIdldiTGhNSW50Q2Vkel9nbVlTWks5SWVvSUMxTVM5YTR5a0FuMDV5WEhQSnRUUG1pTTZYbmJUcWhaSS1yaFZMZG5kZmxBaU5oUkZn?oc=5","date":"2026-03-05","type":"deal","source":"Morningstar","summary":"The Best Healthcare Stocks to Buy - Morningstar","headline":"The Best Healthcare Stocks to Buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOSHllNFZMdUFDU2JhNmpHLTVpQ2hxcHMxeDFqeUtRRVZydUlVNmNucmxWNFdUNWttN1NWRWdHWXYxVzE5Z1hzOWMzR0xjcnczVGxHb0RiV3lJTUtITnAxSnJvSC1nbGVpRW52ZFZZT0MtWHgzcFdaV3hoYThwbE5aVmM2MmdjYVlkMjEyV0w5c3BSbzNacG9IUzFMNE9HbEhJRHFhSHpHX1dwbEtZLTNsVzlZY1pIcEJKU2VOR2J1ZDdTcWNnZHdZWXdnYlpGc1BJdFNwc2Y0MGZWRUk?oc=5","date":"2026-02-10","type":"regulatory","source":"Reuters","summary":"Zimmer Biomet beats quarterly estimates on strong implant demand amid US sales overhaul - Reuters","headline":"Zimmer Biomet beats quarterly estimates on strong implant demand amid US sales overhaul","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPZ0JoNkEyYkIzZzhhQTBpOHA3WlVDZjgzLXY3c2lONzdPeHlFOFBpaEJtUEsycW5ZeS03eXpLQnQ1TE5YRWxNLWFvS0hWWVB6SzBCYnJ0TFpUUEIxTVJ6TUdjWXVyeEFqSENiWTh5RUdzLWtOOEw2VUJ5YVZXVlFMS2FzREMycHFvZ2dCV200b3dfVVVHTDZ1cHVHTVdQdHg4V08zVzRwZ2dkOEU1cXR5WDFHbw?oc=5","date":"2026-02-03","type":"earnings","source":"TradingView","summary":"Zimmer Biomet to Report Q4 Earnings: Here's What to Expect - TradingView","headline":"Zimmer Biomet to Report Q4 Earnings: Here's What to Expect","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPTndxSlR4cV85MklMdUc4Q1JGNnN5ZG1GR0tZRHdMeUdKUG8wVFV4Vm04QktrVENuV3Y2RmpKemJ3OTZpQm5uWTJoclZ3anVZTjB6UmRDTFJPNmlMU21TM1lOTjU5RE9Hb1JSeTEzTWF3ekhFa1pvcGtSb3RtSXJSYTgzcGxnNTdaNkpSMzE4YzhyZGJRVDA4LXRmU0EyX2FUTjJWTkM0Z2FSMGVBWUtCLUh4bDJHV05MR3NaSEhLMjlNOTk5OHYxNmwtekk?oc=5","date":"2026-01-16","type":"earnings","source":"BioSpace","summary":"Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results - BioSpace","headline":"Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNeEJhMFF5c213aktiWnJWclhCRUhtREI1UkVHUWhWOG1FamRjTzBpdzNtQ0VLd1ZDN2pXWHk1LWQ1bUNWNlJvdTRScnpUemJTU3drdDE3NU5PRHNIZVZWUjRKSVU5X0MwVi1QVS04YzQwWDdfLXRQS21vVzZqTDE1MDRNSTVlUTNWNUE?oc=5","date":"2026-01-13","type":"regulatory","source":"Seeking Alpha","summary":"Zimmer Biomet drops after cautious remarks on outlook - Seeking Alpha","headline":"Zimmer Biomet drops after cautious remarks on outlook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPamRXSnB4RXZkQTAtU1RXdWhmUmRlSTVDbUJtWkJxUm1RRmozMXhEUVhZU0ltdXNIN0pXTkllZW82SDZSTlRYVmZSSks1TWlBbG9SRDgtb1RLUl85Y2NSaEIyWldkdXZQNVpxOEl5T3drVWNMOTVULWZQV2xlNVVMVndQV0RQVWxkSHNjdHd2ODNhTTU5T2dLVE0tLW5XX2lhaUE?oc=5","date":"2026-01-03","type":"pipeline","source":"TIKR.com","summary":"Who Owns Zimmer Biomet? Top Shareholders and Recent Insider Trades - TIKR.com","headline":"Who Owns Zimmer Biomet? Top Shareholders and Recent Insider Trades","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPSE42ZlVSQ1R2enNpYnlqUDZVMUR1eC1SWng0ZWNUQlBHbXdTZFlDSHYtelV4TDYzdFBLdW5lMVBrZ0NRTW90QVI1QVhTZzJWZ2FXaGNNODY0QlZDWkxINFk3VTF0Q3BxMDRFNDBOeXJKOVhaT3RhbTFUUkVac0VnLUFKVGp3OTdXVjJJQ0tmYkN5WXlRVm9QR01nYlVDa2k4azF6ZUFRNWdJQlI0bFVYNHF6ODFNdDVUbVNCTkVyeEJPVUpqamFmNkN2a1Vzam9TZDNMNVZZMzdvVGtVY2dLNHRXbw?oc=5","date":"2025-11-05","type":"pipeline","source":"Reuters","summary":"Zimmer cuts 2025 organic sales growth forecast on weakness in international markets - Reuters","headline":"Zimmer cuts 2025 organic sales growth forecast on weakness in international markets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNQkVkNlEtenhhdm9ESWw0ZkU4dmk1ZmJoZW9rc3VvLW11aUlfaWlRS1dNcE02dGk1TjJvV2FCZnlleU1YT0d4NlNJQjRBTEFqZEhadWhsNFNWQkFPRmgyYjNSNDdPeVY3TDRfVGdNTkFSdmlxNW42WUQ5Z24wc3RWS2QyNVhBQk4tSWZGbzBrY3FkSUdwcFVSeHJ4b2xLbVBmT1BZOG9yZ2xNaTZ0WlBfRVJRVQ?oc=5","date":"2025-10-21","type":"earnings","source":"TradingView","summary":"Zimmer Biomet to Report Q3 Earnings: Here's What to Expect - TradingView","headline":"Zimmer Biomet to Report Q3 Earnings: Here's What to Expect","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxOQll1anNYSFdWdUVVb1R0ZlcteWdzUVFOTzJGUUZJRXNzQ1VpSmtndlhjVkM5WTVxNmczWGgweksyNV9acXBRZjkwS3RQRC0waTJNcHZaTFBxcTNBTU5Ub1FfeVpRY3JXSUVheUtuUFN2Zkc5N2Z1cjhhSldMMk9TQlV2VlhrbjNuSVgxVFJZWjRqYmhFUWprM3Q4dDlBV194cUItS0I5cTFSeTdPbzhJcTBWRmFMWDMwa3FTUTdScmZZbG5COUpoLWlDaHhvM1c3bkliYkpNUkVmTVY5Z2RWdFdmRzlJaUNueW82bzZpV2E?oc=5","date":"2025-09-25","type":"regulatory","source":"PR Newswire","summary":"Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System - PR Newswire","headline":"Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5zU0otOFFVQjJzN0hQMWdfNE5Mbm1MOWxkZmd0alh5TER3S1lYczdiQmlpQ3lqcDZDdWg1ZnBVRkV2UXpZVHFHallOWVBHOUJXM3dmQ19aS2h3Z0llSzlLVTVQNFY5R1VrMWJxTlp4ZWtEUFVDNFVBaHlrSQ?oc=5","date":"2025-09-08","type":"pipeline","source":"MassDevice","summary":"Zimmer Biomet sues Deloitte for $172M over ‘disaster’ of a project - MassDevice","headline":"Zimmer Biomet sues Deloitte for $172M over ‘disaster’ of a project","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNTEVERHpMS09vblk3MENycFNvaVRTbXNOZ0Nkc080WDhJV3lXRlV1dTg0OVdrM2Y1QmJGZThvd0RqXzhQU1dhY2VJWlJ4bkdaemJXZmpiNGczZ1JQcnQ2Z3dZWW5NSEd6bWF3R3RyRTljRDNaRV85c3N5X2xqTDAzTmFtcXVqem5vMngxMU1Gb1VaWWxreXNPZE5wVnFrR19wNjlKZDFVbjZkalBwa1BOUkYxUGxOeVB0UDZ2NXJkd3RsdjRaUmhZVERLOHRIZ1Bz?oc=5","date":"2025-08-07","type":"earnings","source":"Reuters","summary":"Zimmer Biomet raises annual profit forecast on lower tariff impact - Reuters","headline":"Zimmer Biomet raises annual profit forecast on lower tariff impact","sentiment":"neutral"}],"patents":[{"drugName":"Persona Knee System","drugSlug":"persona-knee-system","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":1500000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Stryker Corporation (SYK)","Johnson & Johnson (JNJ)","Smith & Nephew plc (SNN)"],"therapeuticFocus":["Orthopedics","Spine"],"financials":{"source":"sec_edgar+yahoo","revenue":8231500000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":8231500000,"period":"2025-12-31"},{"value":7678600000,"period":"2024-12-31"},{"value":7394200000,"period":"2023-12-31"},{"value":6939900000,"period":"2022-12-31"},{"value":7836200000,"period":"2021-12-31"},{"value":7024500000,"period":"2020-12-31"}],"grossProfit":1285400000,"grossProfitHistory":[{"period":"2025-12-31","value":5737800000},{"period":"2024-12-31","value":5487400000},{"period":"2023-12-31","value":5310400000},{"period":"2022-12-31","value":4920400000}],"rdSpend":225600000,"rdSpendHistory":[{"period":"2025-12-31","value":458500000},{"period":"2024-12-31","value":437400000},{"period":"2023-12-31","value":458700000},{"period":"2022-12-31","value":406000000}],"sgaSpend":3257200000,"operatingIncome":1356200000,"operatingIncomeHistory":[{"period":"2025-12-31","value":1356200000},{"period":"2024-12-31","value":1528300000},{"period":"2023-12-31","value":1451300000},{"period":"2022-12-31","value":1192100000}],"netIncome":705100000,"netIncomeHistory":[{"period":"2025-12-31","value":705100000},{"period":"2024-12-31","value":903800000},{"period":"2023-12-31","value":1024000000},{"period":"2022-12-31","value":231400000}],"eps":3.55,"epsHistory":[{"period":"2025-12-31","value":3.55},{"period":"2024-12-31","value":4.43},{"period":"2023-12-31","value":4.88},{"period":"2022-12-31","value":1.1}],"cash":591900000,"cashHistory":[{"period":"2025-12-31","value":591900000},{"period":"2024-12-31","value":525500000},{"period":"2023-12-31","value":415800000},{"period":"2022-12-31","value":375700000}],"totalAssets":23091700000,"totalLiabilities":10385900000,"totalDebt":7519100000,"equity":12697700000,"operatingCashflow":1697100000,"operatingCashflowHistory":[{"period":"2025-12-31","value":1697100000},{"period":"2024-12-31","value":1499400000},{"period":"2023-12-31","value":1581600000},{"period":"2022-12-31","value":1284700000}],"capex":-276900000,"capexHistory":[{"period":"2025-12-31","value":-276900000},{"period":"2024-12-31","value":-356800000},{"period":"2023-12-31","value":-394500000},{"period":"2022-12-31","value":-217600000}],"freeCashflow":1420200000,"dividendsPaid":-190300000,"buybacks":-487000000,"employees":17000,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":849900000,"ebit":370100000,"ebitda":640100000,"period":"2026-03-31","revenue":2086700000,"epsBasic":1.22,"netIncome":238100000,"rdExpense":103400000,"epsDiluted":1.22,"grossProfit":1510500000,"operatingIncome":395100000},{"sga":872300000,"ebit":169900000,"ebitda":453900000,"period":"2025-12-31","revenue":2243700000,"epsBasic":null,"netIncome":139300000,"rdExpense":118700000,"epsDiluted":null,"grossProfit":1451300000,"operatingIncome":282600000},{"sga":811400000,"ebit":354600000,"ebitda":638200000,"period":"2025-09-30","revenue":2001400000,"epsBasic":1.17,"netIncome":230900000,"rdExpense":115900000,"epsDiluted":1.16,"grossProfit":1442100000,"operatingIncome":338300000},{"sga":814800000,"ebit":303900000,"ebitda":575700000,"period":"2025-06-30","revenue":2077300000,"epsBasic":0.77,"netIncome":152800000,"rdExpense":113300000,"epsDiluted":0.77,"grossProfit":1485100000,"operatingIncome":396400000},{"sga":758800000,"ebit":295200000,"ebitda":549600000,"period":"2025-03-31","revenue":1909100000,"epsBasic":0.92,"netIncome":182000000,"rdExpense":110600000,"epsDiluted":0.91,"grossProfit":1359300000,"operatingIncome":338900000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":null,"epsBasic":1.2,"netIncome":null,"rdExpense":null,"epsDiluted":1.2,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":82.99,"previousClose":82.72,"fiftyTwoWeekHigh":108.29,"fiftyTwoWeekLow":79.12,"fiftyTwoWeekRange":"79.12 - 108.29","fiftyDayAverage":89.67,"twoHundredDayAverage":94.37,"beta":0.47,"enterpriseValue":23119917056,"forwardPE":9.2,"priceToBook":1.27,"priceToSales":1.91,"enterpriseToRevenue":2.75,"enterpriseToEbitda":8.96,"pegRatio":0.58,"ebitda":2580999936,"ebitdaMargin":30.7,"freeCashflow":1044124992,"operatingCashflow":1673699968,"totalDebt":7586999808,"debtToEquity":59.8,"currentRatio":1.73,"returnOnAssets":4.1,"returnOnEquity":6.1,"analystRating":"2.6 - Hold","recommendationKey":"hold","numberOfAnalysts":21,"targetMeanPrice":98.52,"targetHighPrice":130,"targetLowPrice":83,"dividendRate":0.96,"payoutRatio":0.25,"fiveYearAvgDividendYield":0.84,"exDividendDate":1774915200,"insiderHeldPercent":0.2,"institutionHeldPercent":106.3,"sharesOutstanding":193462482,"floatShares":192868552,"sharesShort":9996758,"shortRatio":3.97,"shortPercentOfFloat":5.2,"epsTrailing":3.86,"epsForward":8.99,"revenuePerShare":42.68,"bookValue":65.53,"officers":[{"age":50,"name":"Mr. Ivan  Tornos","title":"President, CEO & Chairman of the Board"},{"age":55,"name":"Mr. Wilfred  van Zuilen","title":"Group President of Europe, Middle East & Africa"},{"age":43,"name":"Mr. JehanZeb  Noor","title":"Senior VP, Chief Strategy, Business Development, Innovation & Transformation Officer"},{"age":51,"name":"Mr. Kevin R. Thornal","title":"Group President of Global Businesses & Americas"},{"age":50,"name":"Mr. Paul A. Stellato","title":"Interim CFO, VP, Controller & Chief Accounting Officer"},{"age":null,"name":"Mr. Shaun  Braun","title":"Senior VP & Chief Information and Technology Officer"},{"age":null,"name":"Dr. Jonathan M. Vigdorchik M.D.","title":"Chief Science, Technology & Medical Affairs Officer"},{"age":null,"name":"Mr. David M. DeMartino","title":"Senior Vice President of Investor Relations"}],"industry":"Medical Devices","irWebsite":"http://investor.zimmer.com/","website":"https://www.zimmerbiomet.com","phone":"574 373 3333"}}